Israel Gives Oramed New Patent for Oral Administrations of Exenatide
The Israel Patent Office has granted Israel’s Oramed Pharmaceuticals, a developer of oral drug delivery systems, a patent for its invention, titled “Methods and Compositions for Oral Administrations More...
Study Shows the Rate Smokers Metabolize Nicotine Predicts Best Method of Quitting
The success of different smoking cessation treatments could be predicted by how quickly smokers break down (metabolise) nicotine in their bodies, according to new research published in The Lancet Respiratory More...
Hans-Werner Sinn, Prof. Of Economics and Public Finance: Economics and Its Critics
There is much to criticize in economics nowadays. For example, the profession focuses far too little on political issues and far too much on beating students to death with mathematics. But much current criticism More...
Ilan Nacasch named Syneron’s Chief Brand Officer
Israel’s Syneron Medical Ltd, a global medical aesthetic device company, has appointed Ilan Nacasch to the newly created position of Chief Brand Officer, effective immediately. He will be responsible More...
BioLight and Integra Join in XL Vision Treating Eye Diseases
BioLight and Integra will invest one million dollars in a new firm which will develop drugs for the treatment of eye diseases. Together they will own a 40% stake in X.L. Vision. Technology, designed to improve More...
Killing Deadly Bacteria and Recording over Any Noise: Weekly Good News from Israel
In the 11th Jan 2015 edition of Israel’s good news, the highlights include: · In a chance discovery, Israeli scientists have found a treatment to kill deadly bacteria. · More...
ADHD treatment co Alcobra raises $26 million on Nasdaq
– The company plans a second Phase III trial in the US for ADHD, drawing lessons from the previous Phase III trial. Alcobra Pharmaceuticals Ltd. (Nasdaq: ADHD), which is developing a drug for More...
Gamida Cell Gets FDA Orphan Drug Approval
Israel’s Gamida Cell, a developer of cell therapy technologies and products for transplantation and adaptive immune therapy, announced that orphan drug designation has been granted by the FDA for its investigational More...
Teva launches generic blood pressure treatment in US
– Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has announced : the Food and Drug Administration (FDA) approval and the launch of the generic equivalent of Diovan (Valsartan) tablets in More...
BrainStorm’s NurOwn Stem Cell Therapy gets Positive Results
BrainStorm Cell Therapeutics, an Israeli developer of adult stem cell technologies for neurodegenerative diseases, announced positive final results from its phase 2a clinical trial of NurOwn in amyotrophic More...